Rouzi Abdulrahim A
Department of Obstetrics and Gynaecology, King Abdulaziz University, Jeddah, Saudi Arabia.
Eur J Contracept Reprod Health Care. 2010 Oct;15(5):376-8. doi: 10.3109/13625187.2010.512672.
To report on a unique medical situation after self-obtained use of misoprostol in a country where abortion is illegal.
A 29-year-old woman was seen at 12 weeks' gestation with a history of use of 10,800 microg of misoprostol orally and vaginally over the preceding six weeks. She had experienced mild-to-moderate pelvic pain but no vaginal bleeding. Because the pregnancy was intrauterine and viable, surgical termination could not be carried out. The risks of fetal congenital anomalies due to in utero exposure to misoprostol were discussed with the patient. A detailed ultrasonography at 16 weeks' gestation revealed no anomaly. Vaginal delivery at 38 weeks' gestation resulted in the birth of a baby without discernible congenital anomalies.
In countries where abortion is illegal, women should be informed about the risks associated with unsupervised self-induced abortion with misoprostol.
报告在一个堕胎非法的国家中，自行使用米索前列醇后出现的一种特殊医疗情况。
一名29岁女性在妊娠12周时前来就诊，其在过去六周内口服和阴道使用了10800微克米索前列醇。她经历了轻度至中度的盆腔疼痛，但没有阴道出血。由于妊娠为宫内妊娠且胎儿存活，无法进行手术终止妊娠。与患者讨论了宫内接触米索前列醇导致胎儿先天性异常的风险。妊娠16周时的详细超声检查未发现异常。妊娠38周时经阴道分娩，产下一名无明显先天性异常的婴儿。
在堕胎非法的国家，应告知女性自行使用米索前列醇进行无监管堕胎的相关风险。
